Preventive dendritic cell vaccination induced TGF-βRII frameshift neoantigen-specific T-cells are linked to long-term disease-free survival in Lynch Syndrome patients
I. Jolanda M. de Vries(Radboud University Nijmegen), Mark A.J. Gorris(Salk Institute for Biological Studies), Harm Westdorp(Radboud University Nijmegen), Anna de Goede, Gerty Schreibelt(Radboud University Nijmegen), Reno S. Bladergroen(Princess Máxima Center), Marjolijn J. L. Ligtenberg(Radboud University Nijmegen), Michelle van Rossum(Radboud University Nijmegen), Florian Wimmers(Stanford University), Tanya M. Bisseling(Radboud University Nijmegen), Winald R. Gerritsen(Amsterdam UMC Location Vrije Universiteit Amsterdam), Irıs D. Nagtegaal(Radboud University Nijmegen), Carl G. Figdor(Radboud University Nijmegen), Steve Boudewijns(Bravis Ziekenhuis), Roland P. Kuiper(Princess Máxima Center), Maria van Vugt-van Pinxteren(Radboud University Nijmegen), Asima Abidi(Radboud University Nijmegen), Fokko M. Nagengast, Alexandra Croockewit(Radboud University Nijmegen)
Cited by 3
Related Papers
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy
|Nature Biotechnology|2005|823
Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1
|Nature Genetics|2008|818
Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline <i>CDH1</i> mutation carriers
|Journal of Medical Genetics|2015|567